Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 19 studies | 60% ± 13% | |
| lung | 18 studies | 54% ± 17% | |
| intestine | 12 studies | 54% ± 23% | |
| kidney | 9 studies | 54% ± 19% | |
| brain | 9 studies | 33% ± 16% | |
| bone marrow | 6 studies | 36% ± 22% | |
| liver | 6 studies | 42% ± 15% | |
| pancreas | 5 studies | 57% ± 29% | |
| eye | 5 studies | 33% ± 11% | |
| uterus | 5 studies | 65% ± 23% | |
| lymph node | 5 studies | 59% ± 16% | |
| placenta | 4 studies | 73% ± 30% | |
| adipose | 4 studies | 35% ± 19% | |
| prostate | 4 studies | 47% ± 13% | |
| breast | 4 studies | 60% ± 4% | |
| heart | 3 studies | 31% ± 13% | |
| adrenal gland | 3 studies | 47% ± 15% | |
| esophagus | 3 studies | 56% ± 26% | |
| skin | 3 studies | 38% ± 5% | |
| thymus | 3 studies | 61% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 6680.57 | 328 / 328 | 100% | 240.72 | 178 / 178 |
| skin | 100% | 7529.50 | 1808 / 1809 | 100% | 276.52 | 472 / 472 |
| thymus | 100% | 9478.70 | 653 / 653 | 100% | 285.47 | 604 / 605 |
| prostate | 100% | 5365.59 | 245 / 245 | 100% | 395.26 | 501 / 502 |
| uterus | 100% | 6801.44 | 170 / 170 | 100% | 259.54 | 458 / 459 |
| ovary | 100% | 7235.22 | 180 / 180 | 100% | 201.70 | 429 / 430 |
| kidney | 100% | 5113.09 | 89 / 89 | 100% | 186.00 | 898 / 901 |
| liver | 100% | 6628.21 | 225 / 226 | 100% | 268.62 | 406 / 406 |
| intestine | 100% | 4409.85 | 966 / 966 | 99% | 230.44 | 524 / 527 |
| lung | 100% | 7013.32 | 577 / 578 | 100% | 226.06 | 1150 / 1155 |
| stomach | 100% | 4527.75 | 359 / 359 | 99% | 177.24 | 284 / 286 |
| breast | 100% | 6133.56 | 459 / 459 | 99% | 224.38 | 1109 / 1118 |
| esophagus | 100% | 4132.39 | 1444 / 1445 | 99% | 106.39 | 181 / 183 |
| bladder | 100% | 5387.14 | 21 / 21 | 99% | 251.87 | 497 / 504 |
| adrenal gland | 100% | 6754.39 | 258 / 258 | 98% | 185.25 | 226 / 230 |
| brain | 92% | 1875.65 | 2437 / 2642 | 99% | 157.22 | 700 / 705 |
| adipose | 100% | 6489.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 209.98 | 29 / 29 |
| spleen | 100% | 6319.05 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 164.16 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 169.82 | 1 / 1 |
| blood vessel | 100% | 6793.29 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 219.67 | 79 / 80 |
| peripheral blood | 98% | 4737.36 | 907 / 929 | 0% | 0 | 0 / 0 |
| heart | 90% | 2780.07 | 779 / 861 | 0% | 0 | 0 / 0 |
| muscle | 20% | 297.40 | 162 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0061077 | Biological process | chaperone-mediated protein folding |
| GO_0044829 | Biological process | positive regulation by host of viral genome replication |
| GO_0030593 | Biological process | neutrophil chemotaxis |
| GO_0044794 | Biological process | positive regulation by host of viral process |
| GO_0006457 | Biological process | protein folding |
| GO_0050821 | Biological process | protein stabilization |
| GO_1901873 | Biological process | regulation of post-translational protein modification |
| GO_0060348 | Biological process | bone development |
| GO_0040018 | Biological process | positive regulation of multicellular organism growth |
| GO_0000413 | Biological process | protein peptidyl-prolyl isomerization |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0016020 | Cellular component | membrane |
| GO_0005790 | Cellular component | smooth endoplasmic reticulum |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0034663 | Cellular component | endoplasmic reticulum chaperone complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0042470 | Cellular component | melanosome |
| GO_0005634 | Cellular component | nucleus |
| GO_0070063 | Molecular function | RNA polymerase binding |
| GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
| GO_0051082 | Molecular function | unfolded protein binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0005518 | Molecular function | collagen binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0016018 | Molecular function | cyclosporin A binding |
| Gene name | PPIB |
| Protein name | Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP) Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) |
| Synonyms | CYPB |
| Description | FUNCTION: PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . |
| Accessions | A0A7P0TB45 ENST00000680158.1 ENST00000300026.4 P23284 ENST00000681658.1 ENST00000681397.1 A0A7P0T7U3 A0A7P0Z497 |